Inclusive
7078
Chordia Therapeutics
190A
Kufu Company Holdings
4376
Cube
7112
Souken Ace
1757
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||
Cash from operating activities | 903.50%882.07M | -85.69%87.9M | 112.93%614.3M | 288.5M |
Net profit before non-cash adjustment | 25.69%662.47M | -10.33%527.08M | 186.97%587.82M | --204.84M |
Total adjustment of non-cash items | 112.47%247.37M | 1,073.66%116.43M | -80.48%9.92M | --50.82M |
-Depreciation and amortization | 32.68%153.18M | 31.82%115.45M | 85.44%87.58M | --47.23M |
-Reversal of impairment losses recognized in profit and loss | --15.87M | --0 | ---- | ---- |
-Disposal profit | --20.41M | --0 | ---- | --7.48M |
-Other non-cash items | 5,833.81%57.91M | 101.26%976K | -1,901.03%-77.66M | ---3.88M |
Changes in working capital | 95.00%-27.77M | -3,455.29%-555.6M | -49.57%16.56M | --32.84M |
-Change in receivables | 8.86%-32.46M | -387.88%-35.61M | -29.41%-7.3M | ---5.64M |
-Change in inventory | 76.03%-153.82M | -1,145.95%-641.74M | 134.66%61.36M | ---177.03M |
-Change in prepaid assets | 789.95%132.47M | ---19.2M | ---- | ---- |
-Change in payables | 240.31%38.41M | 74.24%-27.38M | -194.07%-106.27M | --112.97M |
-Provision for loans, leases and other losses | -49.58%1.14M | -13.99%2.27M | 108.76%2.64M | ---30.13M |
-Changes in other current assets | -108.14%-13.52M | 151.08%166.06M | -50.15%66.14M | --132.67M |
Dividends paid (cash flow from operating activities) | ||||
Dividends received (cash flow from operating activities) | ||||
Interest paid (cash flow from operating activities) | -13.91%-24.23M | -25.76%-21.27M | -95.09%-16.92M | -8.67M |
Interest received (cash flow from operating activities) | 5.15%143K | 16.24%136K | 0.86%117K | 116K |
Tax refund paid | 29.76%-208.62M | -263.78%-296.99M | 32.24%-81.64M | -120.48M |
Other operating cash inflow (outflow) | 36.08%21.09M | -35.56%15.5M | 218.84%24.04M | 7.54M |
Operating cash flow | 412.22%670.45M | -139.77%-214.74M | 223.30%539.9M | --167M |
Investing cash flow | ||||
Net PPE purchase and sale | 16.60%-343.47M | 38.20%-411.84M | -349.82%-666.38M | ---148.14M |
Net business purchase and sale | -116.28%-21.94M | --134.74M | --0 | ---- |
Net investment product transactions | 118.67%262K | 98.07%-1.4M | -225.34%-72.73M | --58.02M |
Advance cash and loans provided to other parties | -720.56%-172.32M | 87.13%-21M | ---163.2M | ---- |
Repayment of advance payments to other parties and cash income from loans | 9.56%11.5M | --10.5M | ---- | ---- |
Net changes in other investments | 357.46%28.91M | 69.03%-11.23M | -827.29%-36.26M | ---3.91M |
Investing cash flow | -65.55%-497.05M | 68.01%-300.24M | -898.16%-938.56M | ---94.03M |
Financing cash flow | ||||
Net issuance payments of debt | -189.18%-777.74M | 84.19%872.05M | 125.56%473.45M | --209.9M |
Increase or decrease of lease financing | ---8.44M | --0 | ---- | ---- |
Cash dividends paid | ---60.6M | ---- | ---- | ---- |
Net other fund-raising expenses | 0.00%-1K | 0.00%-1K | 100.00%-1K | ---26.72M |
Financing cash flow | -197.10%-846.78M | 84.19%872.05M | 158.46%473.45M | --183.18M |
Net cash flow | ||||
Beginning cash position | 25.35%1.77B | 5.61%1.41B | 23.77%1.33B | --1.08B |
Current changes in cash | -288.58%-673.39M | 377.45%357.08M | -70.80%74.79M | --256.15M |
Cash adjustments other than cash changes | ---- | ---- | --1K | ---- |
End cash Position | -38.14%1.09B | 25.35%1.77B | 5.61%1.41B | --1.33B |
Free cash flow | 151.24%321.08M | -395.41%-626.58M | -60.58%-126.48M | ---78.76M |
Currency Unit | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |